About this opportunity
Oxford Biomedica lists this Director, Business Development, East Coast opportunity in northern, Kentucky. Review the employer’s description below for duties, qualifications and application requirements.
Job description
Select how often (in days) to receive an alert:
Director, Business Development, East Coast
Location: Home Based, US
Company: oxfordbiom
Join Us in Changing Lives
AtOXB , our people are at the heart of everything we do. We’re on a mission to enable life-changing therapies to reach patients around the world—and we’re looking for passionate individuals who embody our core values every day:Responsible, Responsive, Resilient, and Respectful .
We are currently recruiting for an experienced and dynamic Director of Business Development to join our Global Business Development Team to lead our efforts in expanding our viral vector CDMO services in the East Coast area of the US, ideally located within Pennsylvania or North Carolina.
Your responsibilities in this role would be:
Prospecting and engaging potential customers in the gene therapy and vaccine sectors and fostering long-term relationships that meet OXB’s business objectives
Build and maintain strategic partnerships with key stakeholders, and clients, including biotech companies, research institutions, and industry leaders to expand awareness for OXB capabilities and drive long term growth.
Collaborate with the Global Commercial Operations on the preparation of proposals to win new business as well as partnering with Commercial Program Management teams to manage active customer programs.
Lead contract negotiations with clients, including Clinical and Commercial Supply and Services agreements and Licensing agreements.
Cross collaboration with the wider Global Commercial & Marketing Teams to create compelling value propositions and promotional materials.
Develop and share local market expertise, win/loss analysis, defining opportunities for differentiation, and updating competitive landscape in the CGT market.
You will need:
A degree education (Bachelor or Masters) within Life Sciences, business, PhD and/or MBA also welcome
Proven experience in life sciences companies, pharmaceutical companies, CDMOs or related sectors with a preference for experience working in Cell and Gene therapies
Experience in business development and/or sales & marketing roles for B2B business, preferably in the Pharma/Biopharma sector
Considerable knowledge and understanding within the biologics and.or gene therapy sector ideally within a CDMO or similar business.
Knowledge of the overall structure of biologics process development and GMP manufacturing projects in Pharma & Biotech.
Understanding of commercial & legal contract terms and used for customer contracts, including clinical and commercial supply agreements, process development agreements and license agreements.
Strong communicator, public speaker & cross departmental collaborator both face to face and over digital platforms.
An appreciation of working within a diverse international culture.
This role does not offer sponsorship for work authorization. External applicants must be eligible to work in the United States.
About Us:
OXB (LSE: OXB) is a global quality and innovation-led contract development and manufacturing organisation (CDMO) in cell and gene therapy with a mission to enable its clients to deliver life changing therapies to patients around the world.
One of the original pioneers in cell and gene therapy, OXB has 30 years of experience in viral vectors; the driving force behind the majority of cell and gene therapies. OXB collaborates with some of the world’s most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV), adenovirus and other viral vector types. OXB’s world-class capabilities range from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods and depth of regulatory expertise.
OXB offers a vast number of technologies for viral vector manufacturing, including a 4th generation lentiviral vector system (the TetraVecta™ system), a dual-plasmid system for AAV production, suspension and perfusion process using process enhancers and stable producer and packaging cell lines.
OXB, a FTSE250 and FTSE4Good constituent, is headquartered in Oxford, UK. It has development and manufacturing facilities across Oxfordshire, UK, Lyon and Strasbourg, France, Bedford MA, and Durham NC, US.
Why Join Us?
Wellbeing programs that support your mental and physical health
Career development opportunities to help you grow and thrive
Supportive, inclusive, and collaborative culture
State-of-the-art labs and manufacturing facilities
A company that lives its values: Responsible, Responsive, Resilient, Respect
#J-18808-Ljbffr
Who can apply
Review the original listing for work authorization, qualifications and employer requirements.